The HSDRC Transgenic Models of Skin Disease Core has been successful in integrating transgenic technology into the study of the pathogenesis of skin diseases, making transgenic approaches easily accessible to investigators requesting its services. The technical and intellectual expertise of the Transgenic Models Core have been instrumental in generating valuable mice strains for the projects of over 60 investigators, facilitating the generation of over 100 novel mouse strains. The Transgenic Models Core has offered the following services: generation of transgenic mice by pronuclear injection of DNA constructs, production of targeted embryonic stem (ES) cell lines by electroporation of gene targeting vectors, and microinjection of targeted ES cells into blastocysts for the generation of knockout mouse strains. The transgenic core also has provided advice and training in transgenic technology, ES cell culture techniques, and animal husbandry needed for the establishment and maintenance of transgenic strains. The Transgenic Models Core has facilitated P&F studies and has provided an important method for publicizing the HSDRC and led to the recruitment of new investigators to the HSDRC. A transgenic and knockout database has been developed by the Core to describe transgenic and knockout mouse strains which are available for skin disease research. The considerable expense and training time needed to independently execute transgenic approaches represents a barrier for many investigators that the Transgenic Models Core is able to overcome. The heavy use of this Core demonstrates the continued need for these services. Funds from the Core were used to amplify microinjection services provided by the BWH Core Transgenic Mouse facility, enabling an increase in productivity of the core by 20%. Funds were also used to subsidize the costs of ES cell culture, with a 50-50 cost sharing between the investigator requesting services and the Core. The Core will continue to provide services to assist investigators with the generation of transgenic and knockout mice. The core will also continue to incorporate conditional transgenic and knockout approaches for the study of skin disease. Significantly, these technologies provide investigators with new methods to focus on skin prospectively through the generation of tissue and temporal specific transgenic and knockout mice.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Center Core Grants (P30)
Project #
5P30AR042689-14
Application #
7393282
Study Section
Special Emphasis Panel (ZAR1)
Project Start
2007-04-01
Project End
2009-03-31
Budget Start
2007-04-01
Budget End
2008-03-31
Support Year
14
Fiscal Year
2007
Total Cost
$106,230
Indirect Cost
Name
Brigham and Women's Hospital
Department
Type
DUNS #
030811269
City
Boston
State
MA
Country
United States
Zip Code
02115
Tian, Tian; Jin, Michelle Qiushuang; Dubin, Krista et al. (2017) IL-1R Type 1-Deficient Mice Demonstrate an Impaired Host Immune Response against Cutaneous Vaccinia Virus Infection. J Immunol 198:4341-4351
Pan, Youdong; Tian, Tian; Park, Chang Ook et al. (2017) Survival of tissue-resident memory T cells requires exogenous lipid uptake and metabolism. Nature 543:252-256
Volpicelli, Elgida R; Lezcano, Cecilia; Zhan, Qian et al. (2014) The multidrug-resistance transporter ABCB5 is expressed in human placenta. Int J Gynecol Pathol 33:45-51
Guenova, Emmanuella; Watanabe, Rei; Teague, Jessica E et al. (2013) TH2 cytokines from malignant cells suppress TH1 responses and enforce a global TH2 bias in leukemic cutaneous T-cell lymphoma. Clin Cancer Res 19:3755-63
Majewska-Szczepanik, Monika; Paust, Silke; von Andrian, Ulrich H et al. (2013) Natural killer cell-mediated contact sensitivity develops rapidly and depends on interferon-?, interferon-? and interleukin-12. Immunology 140:98-110
Zadran, Sohila; McMickle, Robert; Shackelford, David et al. (2013) Monitoring extra-vascular migratory metastasis (EVMM) of migrating cancer cells using an in vitro co-culture system. Protoc exch 2013:
Burkhardt, Ute E; Hainz, Ursula; Stevenson, Kristen et al. (2013) Autologous CLL cell vaccination early after transplant induces leukemia-specific T cells. J Clin Invest 123:3756-65
Dowlatshahi, Mitra; Huang, Victor; Gehad, Ahmed E et al. (2013) Tumor-specific T cells in human Merkel cell carcinomas: a possible role for Tregs and T-cell exhaustion in reducing T-cell responses. J Invest Dermatol 133:1879-89
Seneschal, Julien; Clark, Rachael A; Gehad, Ahmed et al. (2012) Human epidermal Langerhans cells maintain immune homeostasis in skin by activating skin resident regulatory T cells. Immunity 36:873-84
Girouard, Sasha D; Laga, Alvaro C; Mihm, Martin C et al. (2012) SOX2 contributes to melanoma cell invasion. Lab Invest 92:362-70

Showing the most recent 10 out of 113 publications